Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
products
FDA Approves First RSV Drug to Protect All Infants
While the virus often leads to mild, coldlike symptoms, it is the leading cause of hospitalization of infants in the U.S. Source link
Cathie Wood's ARK Writes Down Twitter Stake by 47%
Wood is still bullish on Twitter’s long-term outlook and said her fund updates its internal valuations of private companies frequently. Source link
How Allbirds Lost Its Way
Quality complaints—and intractable holes—have dogged the hot shoe company, which rolled out an assortment of new products but found environmental sustainability a tough sell. Source
Factbox-Food and beverage products that mention aspartame on their labels By Reuters
© Reuters. FILE PHOTO: Diet Coke is seen on display at a store in New York City, U.S., June 28, 2023. REUTERS/Shannon Stapleton//File Photo (Reuters)
Drones Reach Stratospheric Heights in Race to Fly Higher, Longer
New military and commercial craft aim to go far higher than jumbo jets and stay there for months, offering a more flexible alternative to satellites.
Johnson & Johnson Sues Doctors Over Studies Linking Talc-Based Products and Cancer
Company says the studies played a significant role in lawsuits over its Baby Powder and Shower to Shower products. Source link
FDA Approves First Over-the-Counter Birth-Control Pill
The Food and Drug Administration approved the first over-the-counter birth-control pill, significantly expanding access to contraception among women across the U.S. Source link
Saudi Arabia to Lose Top Spot in OPEC+
The kingdom is set to fall below Russia as the largest oil producer in the alliance as its production cuts begin to bite, tightening the
Salesforce to raise prices of some cloud products from August By Reuters
© Reuters. FILE PHOTO: A logo of Salesforce is seen at its exhibition space, at the Viva Technology conference dedicated to innovation and startups at
FDA's OK Isn't Always a Happy Day for Biotech Investors
In recent weeks, three closely watched FDA decisions came in positive for the companies—followed by their stocks going negative. Source link